S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69

Invacare Stock Forecast, Price & News

-0.03 (-1.14%)
(As of 01/21/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
527,704 shs
Average Volume
858,815 shs
Market Capitalization
$91.41 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive IVC News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

Invacare logo

About Invacare

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.


Disabled and Elderly Assistive Technologies - GlobeNewswire
December 21, 2021 |  globenewswire.com
See More Headlines

Industry, Sector and Symbol

Surgical appliances & supplies
Health Care Equipment
Year Founded

Sales & Book Value

Annual Sales
$850.69 million
Cash Flow
$0.32 per share
Book Value
$8.65 per share


Net Income
$-28.28 million
Pretax Margin




Free Float
Market Cap
$91.41 million

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

1.80 out of 5 stars

Medical Sector

849th out of 1,418 stocks

Surgical Appliances & Supplies Industry

17th out of 28 stocks

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Invacare (NYSE:IVC) Frequently Asked Questions

Is Invacare a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Invacare stock.
View analyst ratings for Invacare
or view top-rated stocks.

How has Invacare's stock been impacted by COVID-19 (Coronavirus)?

Invacare's stock was trading at $6.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IVC stock has decreased by 56.9% and is now trading at $2.61.
View which stocks have been most impacted by COVID-19

When is Invacare's next earnings date?

Invacare is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Invacare

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) posted its quarterly earnings results on Wednesday, October, 27th. The health services provider reported ($0.12) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.20) by $0.08. The health services provider earned $224.20 million during the quarter, compared to the consensus estimate of $222.27 million. Invacare had a negative trailing twelve-month return on equity of 10.50% and a negative net margin of 6.05%. During the same period in the previous year, the business earned ($0.10) EPS.
View Invacare's earnings history

What guidance has Invacare issued on next quarter's earnings?

Invacare updated its FY 2021 earnings guidance on Wednesday, November, 3rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $839.92 million-$865.37 million, compared to the consensus revenue estimate of $880.88 million.

What price target have analysts set for IVC?

2 Wall Street analysts have issued 1 year target prices for Invacare's shares. Their forecasts range from $8.00 to $9.00. On average, they anticipate Invacare's share price to reach $8.50 in the next twelve months. This suggests a possible upside of 225.7% from the stock's current price.
View analysts' price targets for Invacare
or view top-rated stocks among Wall Street analysts.

Who are Invacare's key executives?

Invacare's management team includes the following people:
  • Matthew E. Monaghan, Chairman, President & Chief Executive Officer
  • Kathleen Patricia Leneghan, Senior VP, Chief Financial & Accounting Officer
  • Angie Goodwin, Chief Technology & Information Officer
  • Anthony C. LaPlaca, Secretary, Chief Administrative Officer & SVP (LinkedIn Profile)
  • Geoffrey Purtill, SVP, General Manager-EMEA & Asia Pacific Region

What is Matthew E. Monaghan's approval rating as Invacare's CEO?

51 employees have rated Invacare CEO Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among Invacare's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO).

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

How do I buy shares of Invacare?

Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invacare's stock price today?

One share of IVC stock can currently be purchased for approximately $2.61.

How much money does Invacare make?

Invacare has a market capitalization of $91.41 million and generates $850.69 million in revenue each year. The health services provider earns $-28.28 million in net income (profit) each year or ($1.52) on an earnings per share basis.

How many employees does Invacare have?

Invacare employs 3,400 workers across the globe.

When was Invacare founded?

Invacare was founded in 1885.

What is Invacare's official website?

The official website for Invacare is www.invacare.com.

Where are Invacare's headquarters?

Invacare is headquartered at ONE INVACARE WAY, ELYRIA OH, 44036.

How can I contact Invacare?

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The health services provider can be reached via phone at (440) 329-6000, via email at [email protected], or via fax at 877-619-7996.

This page was last updated on 1/22/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.